Brief: Recipharm Partners With Aptahem For Formulation Of Apta-1 Drug Candidate
17/12/2019 09:11
Dec 17 (Reuters) - Recipharm AB (publ) RECIb.ST :
* PARTNERS WITH APTAHEM FOR FORMULATION OF APTA-1 DRUG
CANDIDATE
* WILL DEVELOP AN INJECTABLE FORMULATION FOR UPCOMING PHASE
1
STUDY
Source text for Eikon: ID:nWkr2bjPzK
Further company coverage: RECIb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Aptahem AB
See all newsBrief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman